Veeva宣布扩大与罗氏的合作关系 - 美通社
Veeva Announces Expanded Partnership with Roche - PR Newswire
生物技术与制药领域的最新动态
Veeva Announces Expanded Partnership with Roche - PR Newswire
Working together on a net-zero future in healthcare - Roche
Lakers jersey history No. 15 — John Roche - LeBron Wire
Stephen M. Roche Obituary November 22, 2025 - Bond Funeral Home
Recursion Pharmaceuticals Surpasses Third-Quarter Expectations, Announces Milestone with Roche - StocksToTrade
Roche inks $200M pact for Freenome's cancer screening blood test - Fierce Biotech
Friday Five — Oral SERDs eye earlier opportunities, Agios' SCD miss, Avadel's not-so-sleepy bidding war…and more - FirstWord Pharma
Roche inks deal for rights to Freenome cancer tests outside US - MedTech Dive
Regeneron wins 2 Eylea nods, ramping up competition with Roche - Fierce Pharma
UBS Sticks to Its Buy Rating for Roche Holding AG (RHHVF) - The Globe and Mail
Freenome teams up with Roche for cancer screening tests - MobiHealthNews
Olema Pharmaceuticals: Shares Double On Roche's MBC Data - I Preach Caution (NASDAQ:OLMA) - Seeking Alpha
How one veteran strategist says to invest as bubbles in AI and credit may already be bursting - Business Insider
C. Light Named One of Five Selected Projects in the Roche MS Innovation Challenge - Yahoo Finance
Sapphiros announces a strategic agreement with Roche, providing Roche access to 1 billion lateral flow tests and access to future molecular point-of-care tests - Yahoo Finance
KaliVir Immunotherapeutics Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate VET3-TGI in Combination with Atezolizumab (Tecentriq®) in Advanced Solid Tumors - Yahoo Finance
Olema Pharmaceuticals (OLMA) Rethinks Competitive Edge After Roche’s Breast Cancer Trial Success - Yahoo Finance
Roche: Data for Breast Cancer Drug Candidate Giredestrant Support Potential Differentiated Status - Morningstar Canada
Freenome and Roche partner on cancer screening technology for ex-US markets - Medical Device Network
European Commission approves Roche’s Lunsumio subcutaneous for relapsed or refractory follicular lymphoma - Yahoo Finance